The Ischemic Penumbra, Injury Thresholds, and the Therapeutic Window for Acute Stroke
Ann Neurol 36:553-554, 5571994., Ginsberg,M.D.&Pulsinelli,W.A., 1994

Oral and Genital Tardive Pain Syndromes
Neurol 44:2115-2119, Ford,B.,et al, 1994

A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994

Subcutaneous Sumatriptan During the Migraine Aura
Neurol 44:1587-1592, Bates,D.,et al, 1994

Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994

Paraneoplastic Temporal Lobe Epilepsy with Testicular Neoplasm and Atypical Amnesia
neurol 44:1270-1274, Ahern,G.L.,et al, 1994

A Multicenter Double-Blind Placebo-Controlled Trial of Pergolide as an Adjunct to Sinemet in Parkinson's Disease
Movement Disorders, 9:40-471994., Olanow,C.W.,et al, 1994

Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994

Phenytoin and Ranitidine Interaction
Ann Int Med 120:892-893, Tse,C.S.T.&Iagmin,P., 1994

Is There a Problem with Long Term Use of Sumatriptan in Acute Migraine?
BMJ 308:113, Osborne,M.J.,et al, 1994

Reverse Shapiro's Syndrome:Hirayama
K. , et al, Arch Neurol 51:494-49694., , 1994

Prophylactic Neuroprotection for Cerebral Ischemia
Stroke 25:1075-1080, Fisher,M.,et al, 1994

Treatment with D-penicillamine Improves Dopamine D2-Receptor Binding and T2-Signal Intensity in de novo Wilson's Disease
Neurol 44:1079-1082, Schwarz,J.,et al, 1994

Migraine:A Pharmacologic Review with Newer Options and Delivery Modalities
Neurol 44:S13-S17, Baumel,B., 1994

Fluctuating Parkinson's Disease:Treatment with the Long-Acting Dopamine Agonist Cabergoline
Arch Neurol 51:1236-1241, Ahlskog,J.E.,et al, 1994

Clinical Exper from Sweden on Use of Subcutaneously Admin Sumatriptan in Migraine & Cluster Headache
Arch Neurol 51:1256-1261, Dahlof,C.,et al, 1994

Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994

Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993

Evolving Toward Effective Therapy for Acute Ischemic Stroke
JAMA 270:360-364, Fisher,M.&Bogousslavsky,J., 1993

The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Arch Int Med 153:1469-1475, Ganzini,L.,et al, 1993

Prolactin-Secreting Macroadenomas in Adolescents, Response to Bromocriptine Therapy
Am J Dis Child 147:1057-1061, Tyson,D.,et al, 1993

Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993

Postmarketing Study of Cardiovascular Adverse Reactions Associated with Sumatriptan
BMJ 307:1185, Ottervanger,J.P.,et al, 1993

Sumatriptan and Chest Pain
Lancet 341:1564-1565, Hillis,W.S.&MacIntyre,P.D., 1993

Transmural Myocardial Infarction with Sumatriptan
Lancet 341:861-862, Ottervanger,J.P.,et al, 1993

Efficacy of Subcutaneous Sumatriptan in Repeated Episodes of Migraine
Neurol 43:1363-1368, Cady,R.K.,et al, 1993

Expression of Thyrotropin-Receptor mRNA in Healthy and Graves'Disease Retro-Orbital Tissue
Lancet 342:337-338, 3181993., Feliciello,A.,et al, 1993

Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993

Defecatory Function in Parkinson's Disease:Response to Apomorphine
Ann Neurol 33:490-493, Edwards,L.L.,et al, 1993

Multiple System Atrophy & Prog Supranuc Palsy, Dimin Striatal D2 Dopamine Receptor Act by SPECT
Arch Neurol 50:513-516, vanRoyen,E.,et al, 1993

Treatment of Parkinson's Disease
NEJM 329:1021-1027, Calne,D.B., 1993

A Novel Antineuronal Antibody in Stiff-Man Syndrome
Neurol 43:114-120, Darnell,R.B.,et al, 1993

Sumatriptan
Lancet 341:221-224, Bateman,D.N., 1993

Reversible Paraneoplastic Limbic Encephalitis
Neurol 43:2418-2419, Kaniecki,R.&Morris,J.C., 1993

Cabergoline in Parkinson's Disease:Long-Term Follow-up
Neurol 43:2587-2590, Lera,G.,et al, 1993

Multictr Study of Cabergoline, A Long-Acting Dopamine Receptor Agonist, in PD Fluct Resp to Levodopa/Carbidopa
Neurol 43:1981-1984, Lieberman,A.,et al, 1993

Schizophrenia as a Brain Disease, The Dopamine Receptor Story
Arch Neurol 50:1093-1095, 10971993., Seeman,P., 1993

Drug-Induced Movement Disorders:An Overview
In Movement Dis in Neurol & Neuropsych, Blackwell Sci Publ, Boston, 2:21., Miller,L.G.&Jankovic,J., 1992

Sumatriptan for Migraine
The Medical Letter, 34:91-931992., , 1992

Dose Ranging Efficacy & Safety of Subcut Sumatriptan in Acute Treat of Migraine
Arch Neurol 49:1271-1276, Mathew,N.T.,et al, 1992

Endogenous Benzodiazepine Receptor Ligands in Idiopathic Recurring Stupor
Lancet 340:1002-1004, Rothstein,J.D.,et al, 1992

Sumatriptan:Efficacy and Contribution to Migraine Mechanisms
JNNP 55:1103-1105, Pearce,J.M.S., 1992

Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992

Anti-Hu-Associated Pareneoplastic Encephalomyelitis/Sensory Neuronopathy
Medicine 71:59-72, Dalmau,J.,et al, 1992

Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992

Acute Respiratory Failure from Dopamine Agonist Withdrawal
Neurol 42:1843-1844, Riley,D.E.,et al, 1992

Tardive Dyskinesia Associated with Use of Metoclopramide in a Child
J Pediatr 121:983-985, Putnam,P.E.,et al, 1992

Ranitidine Pharmacokinetics and Adverse Central Nervous System Reactions
Arch Int Med 152:2325-2329, Slugg,P.H.,et al, 1992

Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992

Striatal D2 Receptor Status in Patients with Parkinson's Disease, Striatonigral Degeneration, and PSP, (PET)
Ann Neurol 31:184-192, Brooks,D.J.,et al, 1992